Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...] …
Category: Providers
The Health Resources and Services Administration (HRSA) has announced plans to host a webinar for federal grantees just days prior [...] …
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...] …
A senior Indiana state senator introduced a bill this week that would require 340B providers to annually report detailed financial [...] …
The nation’s leading hospital group warned the decision by federal regulators not to address 340B policy in a new proposed [...] …
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...] …
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...] …
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...] …
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...] …
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...] …